Open AccessVEGF Expression to Support Targeted Therapy in Ovarian Surface Epithelial Neoplasms
Author(s) -
Sudeshna Mukherjee,
Mallika Pal,
Susmita Mukhopadhyay,
Indranil Das,
Rathin Hazra,
Sue Ghosh,
Rajib Mondal,
Runa Bal
Publication year - 2017
Publication title -
journal of clinical and diagnostic research
Language(s) - English
Resource type - Journals
eISSN - 2249-782X
pISSN - 0973-709X
DOI - 10.7860/jcdr/2017/24670.9737
Subject(s) - serous fluid , immunohistochemistry , medicine , vascular endothelial growth factor , angiogenesis , pathology , stage (stratigraphy) , oncology , vegf receptors , biology , paleontology
Vascular Endothelial Growth Factor (VEGF), a promoter of angiogenesis, is a promising target for anti-angiogenic therapy in ovarian cancer. In our study, we examined the expression of VEGF in the spectrum of epithelial ovarian neoplasms (benign, borderline and malignant) by Immunohistochemistry (IHC).